Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Circumpolar Health ; 74: 28952, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26294193

RESUMO

BACKGROUND: Canadian First Nation populations have experienced endemic and epidemic tuberculosis (TB) for decades. Vitamin D-mediated induction of the host defence peptide LL-37 is known to enhance control of pathogens such as Mycobacterium tuberculosis. OBJECTIVE: Evaluate associations between serum levels of 25-hydroxy vitamin D (25(OH)D) and LL-37, in adult Dene First Nation participants (N = 34) and assess correlations with single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP). DESIGN: Venous blood was collected from all participants at baseline (winter and summer) and in conjunction with taking vitamin D supplements (1,000 IU/day) (winter and summer). Samples were analysed using ELISA for concentrations of vitamin D and LL-37, and SNPs in the VDR and VDBP regions were genotyped. RESULTS: Circulating levels of 25(OH)D were not altered by vitamin D supplementation, but LL-37 levels were significantly decreased. VDBP and VDR SNPs did not correlate with serum concentrations of 25(OH)D, but LL-37 levels significantly decreased in individuals with VDBP D432E T/G and T/T, and with VDR SNP Bsm1 T/T genotypes. CONCLUSIONS: Our findings suggest that vitamin D supplementation may not be beneficial as an intervention to boost innate immune resistance to M. tuberculosis in the Dene population.


Assuntos
Peptídeos Catiônicos Antimicrobianos/genética , Doenças Endêmicas , Receptores de Calcitriol/genética , Tuberculose/epidemiologia , Proteína de Ligação a Vitamina D/genética , Vitamina D/análogos & derivados , Adulto , Canadá/epidemiologia , Estudos de Coortes , Feminino , Marcadores Genéticos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Grupos Populacionais , Estudos Prospectivos , Medição de Risco , Tuberculose/sangue , Tuberculose/tratamento farmacológico , Tuberculose/genética , Vitamina D/administração & dosagem , Vitamina D/sangue , Catelicidinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA